Aligos Therapeutics Stock Options

ALGS Stock  USD 11.44  1.16  11.28%   
Aligos Therapeutics' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.51. The Aligos Therapeutics option chain provides detailed quote and price information for the current Aligos Therapeutics option contracts. It shows all of Aligos Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Aligos Therapeutics

Analyzing Aligos Therapeutics' in-the-money options over time can help investors to take a profitable long position in Aligos Therapeutics regardless of its overall volatility. This is especially true when Aligos Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Aligos Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Aligos Therapeutics' stock while costing only a fraction of its price.

Aligos Current Options Market Mood

Aligos Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Aligos Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Aligos Therapeutics' options investors are not very successful. Aligos Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Aligos contract

Base on the Rule 16, the options market is currently suggesting that Aligos Therapeutics will have an average daily up or down price movement of about 0.0944% per day over the life of the 2025-03-21 option contract. With Aligos Therapeutics trading at USD 11.44, that is roughly USD 0.0108. If you think that the market is fully incorporating Aligos Therapeutics' daily price movement you should consider buying Aligos Therapeutics options at the current volatility level of 1.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Aligos Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Aligos calls. Remember, the seller must deliver Aligos Therapeutics stock to the call owner when a call is exercised.

Aligos Therapeutics Option Chain

When Aligos Therapeutics' strike price is surpassing the current stock price, the option contract against Aligos Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Aligos Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Aligos. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Aligos. It also shows strike prices and maturity days for a Aligos Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
ALGS1250321C0000750007.50.0 - 0.50.5Out
Call
ALGS1250321C0000500005.00.0 - 0.50.5Out
Call
ALGS1250321C00002500142.50.0 - 0.50.5Out
Call
ALGS250321C0000750007.50.0 - 4.74.7Out
Call
ALGS250321C0000500005.00.0 - 4.74.7Out
Call
ALGS250321C00002500502.50.05 - 0.30.05Out
 Put
ALGS1250321P0000750007.56.6 - 7.66.6Out
 Put
ALGS1250321P0000500005.04.2 - 5.04.2Out
 Put
ALGS1250321P0000250002.51.9 - 2.41.9Out
 Put
ALGS250321P0000750007.53.8 - 7.53.8Out
 Put
ALGS250321P0000500005.01.35 - 5.01.35Out
 Put
ALGS250321P0000250002.50.0 - 2.52.5Out

Aligos Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Aligos Total Stockholder Equity

Total Stockholder Equity

(27.52 Million)

At this time, Aligos Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year.

Aligos Therapeutics Corporate Management

Additional Tools for Aligos Stock Analysis

When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.